AT
Allotera Therapeutics, Inc.
SEC filingOther Health Care · St. Louis, MO
Amount raised$123.3Msold at filing
Total offering$163M$39.7M still open
Investors in the raise20count reported to the SEC
FiledJul 23, 2026first sale Aug 22, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Drew DennisonDirector
Kevin LiDirector
Natalie MountDirector
Niall O'DonnellDirector
Kumar SrinivasanExecutive Officer, Director
Matthew CooperExecutive Officer
Bosun HauDirector
Peter KienerDirector
Cherry ThomasExecutive Officer
Ayman KabakibiExecutive Officer
Bali MuralidharDirector
Executive officers, directors and promoters as listed on the Form D.